Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.81
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $790.02 million as of April 28, 2026. Its market cap has increased by 381.59% in one year.
Market Cap
790.02M
Enterprise Value
572.33M
1-Year Change
381.59%
Ranking
Category
Stock Price
$12.81
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $790.02M, a decrease of -64.19%. That is a compound annual growth rate of -18.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 790.64M | 47.97% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 840.42M |
| Arbutus Biopharma | 818.28M |
| Crescent Biopharma | 796.17M |
| ARS Pharmaceuticals | 788.42M |
| Kura Oncology | 783.77M |
| Vor Biopharma | 779.19M |
| Cullinan Therapeutics | 774.13M |
| SpyGlass Pharma | 762.29M |